This inventor holds 2 USPTO granted patents. Top assignees: Cell Genesys, Inc., Geron Corporation. Active years: 2005-2006.
Company Filing History:
Years Active: 2005-2006
Title: Michael Mok: Innovator in Stem Cell Research
Introduction
Michael Mok is a prominent inventor based in Palo Alto, California. He has made significant contributions to the field of stem cell research, particularly in the development of systems that enhance the quality and applicability of human embryonic stem cells. With a total of 2 patents, Mok's work is pivotal in advancing regenerative medicine.
Latest Patents
One of Mok's latest patents is a marker system for preparing and characterizing high-quality human embryonic stem cells. This innovative system provides a method for qualifying embryonic stem cells intended for human therapy. A large-scale sequencing project has identified important markers characteristic of undifferentiated pluripotent cells. Combinations of these markers can validate the self-renewing capacity of embryonic stem cells and their ability to differentiate into tissue types suitable for regenerative medicine. The marker system has been utilized to screen feeder cells, media additives, and culture conditions that promote the proliferation of stem cells without differentiation. Furthermore, a culture system optimized by following these markers is suitable for the rapid expansion of undifferentiated cells from existing lines or the derivation of new lines that are equally appropriate for clinical use. Another notable patent involves a quantitative assay of host cell DNA in a sample, which detects members of a conserved, dispersed gene family to ascertain levels of host cell genomic DNA.
Career Highlights
Throughout his career, Michael Mok has worked with several notable companies, including Cell Genesys, Inc. and Geron Corporation. His experience in these organizations has contributed to his expertise in stem cell technology and regenerative medicine.
Collaborations
Mok has collaborated with esteemed colleagues such as John M. Irving and Kenneth Ho, further enhancing the impact of his research in the scientific community.
Conclusion
Michael Mok's innovative work in stem cell research and his contributions to the development of marker systems for embryonic stem cells highlight his importance in the field. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options for patients.